MORGAN STANLEY - SYNTA PHARMACEUTICALS CORP ownership

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2016$3,0000.0%8,816
-23.8%
0.00%
Q1 2016$3,000
-78.6%
11,573
-69.8%
0.00%
Q4 2015$14,000
-81.1%
38,298
-10.9%
0.00%
Q3 2015$74,000
-38.8%
42,986
-20.8%
0.00%
Q2 2015$121,000
-67.4%
54,305
-71.7%
0.00%
Q1 2015$371,000
-77.8%
191,827
-69.6%
0.00%
-100.0%
Q4 2014$1,670,000
+81.7%
630,445
+106.3%
0.00%
Q3 2014$919,000
+99.8%
305,601
+172.1%
0.00%
Q2 2014$460,000
+27.4%
112,330
+34.4%
0.00%
Q1 2014$361,000
+7.1%
83,582
+30.0%
0.00%
Q4 2013$337,000
+23.9%
64,286
+49.6%
0.00%
Q3 2013$272,000
-64.2%
42,982
-71.8%
0.00%
Q2 2013$760,000152,1980.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q3 2016
NameSharesValueWeighting ↓
CAXTON CORP 37,069,140$64,500,00087.00%
ARMISTICE CAPITAL, LLC 2,000,000$3,480,0001.19%
IRONWOOD INVESTMENT MANAGEMENT LLC 432,259$752,0000.28%
Geller Advisors LLC 187,323$326,0000.21%
CAXTON CORP 57,000$99,0000.13%
Verity Asset Management, Inc. 64,476$112,0000.11%
TFS CAPITAL LLC 367,364$639,0000.06%
Cutler Capital Management, LLC 72,500$126,0000.06%
LUCAS CAPITAL MANAGEMENT 21,100$37,0000.02%
Nine Chapters Capital Management LLC 129,700$226,0000.02%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders